scPharmaceuticals (SCPH) Revenue & Revenue Breakdown
scPharmaceuticals Revenue Highlights
Latest Revenue (Y)
$13.59M
Latest Revenue (Q)
$8.05M
scPharmaceuticals Revenue by Period
scPharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $13.59M | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | - |
scPharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $8.05M | 31.99% |
2024-03-31 | $6.10M | 0.10% |
2023-12-31 | $6.10M | 60.59% |
2023-09-30 | $3.80M | 131.75% |
2023-06-30 | $1.64M | -20.60% |
2023-03-31 | $2.06M | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | - |
scPharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MCRB | Seres Therapeutics | $126.33M | - |
SCPH | scPharmaceuticals | $13.59M | $8.05M |
CNTA | Centessa Pharmaceuticals | $6.88M | - |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
IOVA | Iovance Biotherapeutics | $1.19M | $58.55M |
MIST | Milestone Pharmaceuticals | $1.00M | - |
DMAC | DiaMedica Therapeutics | - | - |
MNPR | Monopar Therapeutics | - | - |
ONCY | Oncolytics Biotech | - | - |
KTTA | Pasithea Therapeutics | - | - |